Morphosys competitive analysis

Explore patent oppositions filed by Morphosys against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFERNov 17, 2021
High Througput Methods For Characterization Of AntibodiesGENMABJan 25, 2019
Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHEOct 10, 2018
Wash Solution And Method For Affinity ChromatographyNOVARTISJun 6, 2018
Compositions Comprising Cross-Species-Specific Antibodies And Uses ThereofAMGEN RESEARCH MUNICHAug 30, 2017
Therapeutic Canine Immunoglobulins And Methods Of Using The SameNEXVET AUSTRALIAMay 3, 2017
Psma AntibodiesPSMAJul 13, 2016

Explore Morphosys's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 21, 2018Methods For Identification Of An Antibody Or A Target1
Apr 8, 2015Anti-Cd38 Human Antibodies And Uses Therefor4

Latest PTAB cases involving Morphosys

Discover the latest PTAB cases involving Morphosys, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Morphosys with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MORPHOSYS75 - -
F HOFFMANN LA ROCHE34247 - -
GENENTECH - 131 - 66
GENMAB911 - -